Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression

被引：102

作者：

Huang, Y ^{[1
]}

Kong, WP ^{[1
]}

Nabel, GJ ^{[1
]}

机构：

[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA

来源：

JOURNAL OF VIROLOGY | 2001年 / 75卷 / 10期

关键词：

D O I：

10.1128/JVI.75.10.4947-4951.2001

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Immunity to human immunodeficiency virus virion-like structures or a polyprotein has been examined after DNA immunization with Rev-independent expression vectors. A Gag-Pol fusion protein stimulated cytotoxic T lymphocyte and antibody responses to Gag and Pol, while a Gag-Pol pseudoparticle did not elicit substantial Pol responses. This fusion protein may be useful for AIDS vaccines.

引用

页码：4947 / 4951

页数：5

共 29 条

[1] VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
BORROW, P
LEWICKI, H
HAHN, BH
SHAW, GM
OLDSTONE, MBA
[J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 6103 - 6110
[2] HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA
CHEN, C
OKAYAMA, H
[J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) : 2745 - 2752
[3] TUMORIGENICITY AND LYSIS BY NATURAL KILLERS
COLLINS, JL
PATEK, PQ
COHN, M
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 153 (01) : 89 - 106
[4] A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers
Evans, TG
Keefer, MC
Weinhold, KJ
Wolff, M
Montefiori, D
Gorse, GJ
Graham, BS
McElrath, MJ
Clements-Mann, ML
Mulligan, MJ
Fast, P
Walker, MC
Excler, JL
Duliege, AM
Tartaglia, J
[J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) : 290 - 298
[5] Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: Implications for antigen-specific immunotherapy
Ferrari, G
Berend, C
Ottinger, J
Dodge, R
Bartlett, J
Toso, J
Moody, D
Tartaglia, J
Cox, WI
Paoletti, E
Weinhold, KJ
[J]. BLOOD, 1997, 90 (06) : 2406 - 2416
[6] Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies
Gorse, GJ
Patel, GB
Mandava, MD
Belshe, RB
[J]. VACCINE, 1999, 18 (9-10) : 835 - 849
[7] AN EPITOPE IN HUMAN IMMUNODEFICIENCY VIRUS-1 REVERSE-TRANSCRIPTASE RECOGNIZED BY BOTH MOUSE AND HUMAN CYTOTOXIC LYMPHOCYTES-T
HOSMALIN, A
CLERICI, M
HOUGHTEN, R
PENDLETON, CD
FLEXNER, C
LUCEY, DR
MOSS, B
GERMAIN, RN
SHEARER, GM
BERZOFSKY, JA
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) : 2344 - 2348
[8] Importance of ribosomal frameshifting for human immunodeficiency virus type 1 particle assembly and replication
Hung, M
Patel, P
Davis, S
Green, SR
[J]. JOURNAL OF VIROLOGY, 1998, 72 (06) : 4819 - 4824
[9] OVEREXPRESSION OF THE HIV-1 GAG-POL POLYPROTEIN RESULTS IN INTRACELLULAR ACTIVATION OF HIV-1 PROTEASE AND INHIBITION OF ASSEMBLY AND BUDDING OF VIRUS-LIKE PARTICLES
KARACOSTAS, V
WOLFFE, EJ
NAGASHIMA, K
GONDA, MA
MOSS, B
[J]. VIROLOGY, 1993, 193 (02) : 661 - 671
[10] KINETICS OF GAG-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES DURING THE CLINICAL COURSE OF HIV-1 INFECTION - A LONGITUDINAL ANALYSIS OF RAPID PROGRESSORS AND LONG-TERM ASYMPTOMATICS
KLEIN, MR
VANBAALEN, CA
HOLWERDA, AM
KERKHOFGARDE, SR
BENDE, RJ
KEET, IPM
EEFTINCKSCHATTENKERK, JKM
OSTERHAUS, ADME
SCHUITEMAKER, H
MIEDEMA, F
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) : 1365 - 1372

← 1 2 3 →